ARCHIVES

Patenting the Gene: Cancer Advocates and Industry Diverge on Myriad Ruling

This article is from The Cancer Letter archive.

Vol. 39 No. 24 | June 14, 2013

Download PDF Visit The Full Archive

Related Articles

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

Firm Begins Phase II Trial Of LDP-341 For Myeloma.

March 30, 2001

NCI Advisors Approve New Grant Programs Worth $100 Million

March 27, 2009

Shortfall In Centers Budget Threatens Grants Of Half Of The 17 Competing For Renewal In 1980

October 12, 1979

Bush Names 8 to NCAB.

June 13, 2008

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996